USPTO Trademark Record · Serial No. 86121578
Trademark details
It was initially claimed by Sarepta Therapeutics, Inc. on 20131118.
That brand applies to the following goods and services:chemical compounds and additives for use in pharmaceutical research or the manufacture of pharmaceuticals, pharmaceuticals and pharmaceutical products for treating muscular dystrophy, infectious diseases and viruses that respond to ribonucleic acid (RNA)-based therapies; pharmaceuticals comprising drugs based on Phosphorodiamidate Morpholino Oligomers technology platform, and drugs that modulate RNA expression, medical and scientific research services, namely, medical research; medical and scientific research services all in the field of muscular dystrophy, infectious diseases and viruses that respond to ribonucleic acid (RNA) modulation therapies.
Currently that trademark is represented by trademark attorney(s): Paul C. Llewellyn.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
